• Home
  • Search Results
  • Quantification of andrographolide sodium bisulphite in urine after intravenous injection to rats by LC-MS/MS.

Quantification of andrographolide sodium bisulphite in urine after intravenous injection to rats by LC-MS/MS.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011-12-02)
Shuang-Qing Zhang, Xiang-Hong Chen, Min Yu, Xu Sun, Zuo-Gang Li
ABSTRACT

A liquid chromatography-tandem mass spectrometry method for the determination of andrographolide sodium bisulphite (ASB) in rat urine was established and validated. To our knowledge, the analytical method is the first developed assay for the determination of ASB in urine samples. Dehydroandrographolide (DAG) was used as an internal standard. ASB and DAG were separated on a C(18) column and detected at negative ion mode using the mass transitions of m/z 413.2→287.2 and m/z 331.2→303.3, respectively. Good linearity was obtained over the range of 50-5000 ng/mL and the correlation coefficient was better than 0.99. The intra- and inter-day accuracy at all levels fell in the ranges of 85.8-101.4% and 87.9-97.5%, and the intra- and inter-day precision (RSD) were in the ranges of 4.3-11.2% and 8.4-13.3%, respectively. The recovery ranged from 96.1% to 98.3% and the matrix effects from 96.2% to 98.1%. Good stability was found under tested conditions. The method was successfully applied to a urinary excretion study of ASB in rats following intravenous administration of 80 mg/kg ASB.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium bisulfite, ACS reagent
Sigma-Aldrich
Sodium bisulfite solution, purum, ~40%
Sigma-Aldrich
Sodium bisulfite, anhydrous, free-flowing, Redi-Dri, ACS reagent

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.